Targeted ablation of Abcc1 or Abcc3 in Abcc6-/- mice does not modify the ectopic mineralization process

Experimental Dermatology

Volumn 16, Issue 10, 2007, Pages 853-859

  Li, Qiaoli ^a   Jiang, Qiujie ^a   Larusso, Jennifer ^a   Klement, John F ^a   Sartorelli, Alan C ^b   Belinsky, Martin G ^c   Kruh, Gary D ^c   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b YALE CANCER CENTER   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Abcc6; Animal models of human disease; Connective tissue mineralization; Pseudoxanthoma elasticum; Targete ablation of Abcc genes

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C1; ABC TRANSPORTER C10; ABC TRANSPORTER C12; ABC TRANSPORTER C2; ABC TRANSPORTER C3; ABC TRANSPORTER C4; ABC TRANSPORTER C5; ABC TRANSPORTER C6; ABC TRANSPORTER C7; ABC TRANSPORTER C8; ABC TRANSPORTER C9; CALCIUM; CARRIER PROTEIN; MESSENGER RNA; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HISTOPATHOLOGY; MALE; MINERALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PSEUDOXANTHOMA ELASTICUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCINOSIS; CONNECTIVE TISSUE; FEMALE; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN ISOFORMS; PSEUDOXANTHOMA ELASTICUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; VIBRISSAE;

EID: 34548493908     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00621.x     Document Type: Article

References (45)

1. Neldner K H. Pseudoxanthoma elasticum. Clin Dermatol 1988: 6: 1-159.
2. Ringpfeil F, Pulkkinen L, Uitto J. Molecular genetics of pseudoxanthoma elasticum. Exp Dermatol 2001: 10: 221-228.
3. Ringpfeil F, McGuigan K, Fuchsel L et al. Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosity. J Invest Dermatol 2006: 126: 782-786.
4. Bergen A A, Plomp A S, Schuurman E J et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000: 25: 228-231.
5. Le Saux O, Urban Z, Tschuch C et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000: 25: 223-227.
6. Miksch S, Lumsden A, Guenther U P et al. Molecular genetics of pseudoxanthoma elasticum: Type and frequency of mutations in ABCC6. Hum Mutat 2005: 26: 235-248.
7. Ringpfeil F, Lebwohl M G, Christiano A M, Uitto J. Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 2000: 97: 6001-6006.
8. Struk B, Cai L, Zach S, Ji W, Chung J, Lumsden A. Mutations of the gene encoding the transmembrane transporter protein ABCC6 cause pseudoxanthoma elasticum. J Mol Med 2000: 78: 282-286.
9. Deeley R G, Westlake C, Cole S P C. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006: 86: 849-899.
10. Uitto J. The gene family of ABC transporters - novel mutations, new phenotypes. Trends Mol Med 2005: 11: 341-343.
11. Kruh G D, Belinsky M G, Gallo J M, Lee K. Physiological and pharmacological function of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer Metastasis Rev 2007: 26: 5-14.
12. Hirohashi T, Suzuki H, Ito K et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 1998: 53: 1068.
13. Johnson B M, Zhang P, Schuetz J D, Brouwer K L R. Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats. Drug Metab Dispos 2006: 34: 556-562.
14. Konig J, Rost D, Cui Y, Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999: 29: 1156-1163.
15. Belinsky M G, Kruh G D. MOAT-E (ARA) is a full length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer 1999: 80: 1342-1349.
16. Kool M, van der Linden M, de Haas M, Baas F, Boorst P. Expression of human MRP6, a homologue of the multidrug resistance protein MRP1, in tissues and cancer cells. Cancer Res 1999: 59: 175-182.
17. Scheffer G L, Hu X, Pijnenborg A C, Wijnholds J, Bergen A A, Scheper R J. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 2002: 82: 515-518.
18. Belinsky M G, Chen Z S, Shchaveleva I, Zeng H, Kruh G D. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 2002: 62: 6172-6177.
19. Iliás A, Urban Z, Seidl T L et al. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 2002: 277: 16860-16867.
20. Lorico A, Rappa G, Finch R A, Yang D, Flavell R A, Sartorelli A C. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 1997: 57: 5238-5242.
21. Wijnholds J, Evers R, van Leusden M R et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 1997: 3: 1275-1279.
22. Belinsky M G, Dawson P A, Shchaveleva I et al. Analysis of the in vivo functions of Mrp3. Mol Pharmacol 2005: 68: 160-168.
23. Klement J F, Matsuzaki Y, Jiang Q-J et al. Targeted ablation of the ABCC6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 2005: 25: 8299-8310.
24. Jiang Q, Li Q, Uitto J. Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: Systemic and local regulatory factors. J Invest Dermatol 2007: 127: 1392-1402.
25. Gorgels T G, Hu X, Scheffer G L et al. Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 2005: 14: 1763-1773.
26. Renie W A, Pyeritz R E, Combs J, Fine S L. Pseudoxanthoma elasticum: High calcium intake in early life correlates with severity. Am J Med Genet 1984: 19: 235-244.
27. Aherrahrou Z, Doehring L C, Kaczmarek P M et al. Ultrafine mapping of Dyscalc1 to an 80 Kb chromosomal segment on chromosome 7 in mice susceptible for dystrophic calcification. Physiol Genomics 2007: 28: 203-212.
28. Ivandic B T, Utz H F, Kaczmarek P M et al. New Dyscalc loci for myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Physiol Genomics 2001: 6: 137-144.
29. Ivandic B T, Qiao J-H, Machleder D, Liao F, Drake T A, Lusis A J. A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Proc Natl Acad Sci USA 1996: 93: 5483-5488.
30. Korff S, Schoensiegel F, Riechert N, Weichenhan D, Katus H A, Ivandic B T. Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. Physiol Genomics 2006: 25: 387-392.
31. Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996: 23: 1061-1066.
32. Paulusma C C, Kool M, Bosma P J et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997: 25: 1539-1542.
33. Wada M, Toh S, Taniguchi K et al. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet 1998: 7: 203-207.
34. Hosokawa S, Tagaya O, Mikami T et al. A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions. Lab Anim Sci 1992: 42: 27-34.
35. Jansen P L, Peters W H, Lamers W H. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985: 5: 573-579.
36. Chu X Y, Strauss J R, Mariano M A et al. Characterization of mice lacking the multidrug resistance protein Mrp2 (Abcc2). J Pharmacol Exp Ther 2006: 317: 579-589.
37. ATP channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci USA 2001: 98: 11760-11764.
38. Grubb B R, Boucher R C. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 1999: 79: 193-214.
39. Seghers V, Nakazaki M, DeMayo F, Aguilar-Bryan L, Bryan J. Sur 1 knockout mice. J Biol Chem 2000: 275: 9270-9277.
40. Shiota C, Larsson O, Shelton K D et al. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 2002: 227: 37176-37183.
41. El-Maadawy S, Kaartinen M T, Schinke T, Murshed M, Karsenty G, McKee M D. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 2003: 44: 272-278.
42. Jahnen-Dechent W, Schinke T, Trindl A et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997: 272: 31496-31503.
43. Luo G, Ducy P, McKee M D et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997: 386: 78-81.
44. Wang W, Xu J, Du B, Kirsch T. Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol 2005: 25: 312-323.
45. Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Gotting C. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 2006: 52: 227-234.